O-Glycan inhibitors generate aryl-glycans, induce apoptosis and lead to growth inhibition in colorectal cancer cell lines
The DOI matches its Crossref record; 51 of the 54 references it cites were found in a registry or an index.
Abstract
Our studies provide direct evidence that O-glycosylation pathways play a role in the regulation of cell growth through apoptosis and proliferation pathways. A series of small molecular weight analogs of the GalNAc-alpha-1-O-serine/threonine structure based on 1-benzyl-2-acetamido-2-deoxy-alpha-O-d-galactopyranoside have been synthesized and tested in the human colorectal cancer cell lines PC/AA/C1/SB10C and HCA7/C29. Three inhibitors, 1-benzyl-2-acetamido-2-deoxy-alpha-O-D-galactopyranoside, and the corresponding 2-azido- and C-glycoside analogs were screened in these colorectal cancer cell lines at 0.5 mM and showed induction of apoptosis and downregulation of proliferation. Treatment of both cell lines with inhibitors led to changes in glycosylation detected with peanut lectin. The inhibition of glycosyltransferase activity in cell homogenates from human colorectal mucosal cells and cultured cell lines could be shown. The competitive action of the inhibitors resulted in the intracellular formation of 28 aryl-glycan products which were identified by MALDI and electrospray mass spectroscopy. The structures showed a differential pattern for each of the inhibitors in both cell lines. Gene array analysis of the glycogenes illustrated a pattern of glycosyltransferases that matched the glycan structures found in glycoproteins and aryl-glycans formed in the PC/AA/C1/SB10C cells; however, there was no action of the three inhibitors on glycogene transcript levels. The inhibitors act at both intermediary metabolic and genomic levels, resulting in altered protein glycosylation and aryl-glycan formation. These events may play a part in growth arrest.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Citations
Cites
Glycans in cancer and inflammation — potential for therapeutics and diagnostics
Dube, D. H., & Bertozzi, C. R. (2005) · Nature Reviews Drug Discovery · doi:10.1038/nrd1751 · Cited by 1,598
The sweet and sour of cancer: glycans as novel therapeutic targets
Fuster, M. M., & Esko, J. D. (2005) · Nature Reviews Cancer · doi:10.1038/nrc1649 · Cited by 1,383 · cited 3×
“Glycosylation of cellular and membrane proteins includes N - and O -linked glycoproteins, proteoglycans, and glycosylphosphatidylinositol (GPI) anchors (Schachter and Brockhausen 1992; Fuster and Esko 2005).”
BackgroundModulation of apoptosis and Bcl-2 expression by prostaglandin E2 in human colon cancer cells.
Sheng, H., Shao, J., Morrow, J. D., Beauchamp, R. D., & Dubois, R. N. (1998) · PubMed · Cited by 1,236
Mucins in the mucosal barrier to infection
Linden, S. K., Sutton, P., Karlsson, N. G., Korolik, V, & McGuckin, M. A. (2008) · Mucosal Immunology · doi:10.1038/mi.2008.5 · Cited by 1,234 · cited 2×
“The mucin-type Oglycan chains are linked to serine and threonine through an α-O-glycosyl linkage to N-acetylgalactosamine in well-defined core structures (Corfield et al. 2001; Linden et al. 2008).”
BackgroundChemical remodelling of cell surfaces in living animals
Prescher, J. A., Dube, D. H., & Bertozzi, C. R. (2004) · Nature · doi:10.1038/nature02791 · Cited by 842 · cited 4×
“2000), and studies with other glycosylation inhibitors have employed peracetylated derivatives to improve uptake (Sarkar et al. 2000; Prescher et al. 2004; Dube and Bertozzi 2005).”
BackgroundInfluentialStructure and Function of the Polymeric Mucins in Airways Mucus
Thornton, D. J., Rousseau, K., & McGuckin, M. A. (2008) · Annual Review of Physiology · doi:10.1146/annurev.physiol.70.113006.100702 · Cited by 823 · cited 2×
“The mucin-type O-glycans are abundant as components of the mucosal protective barrier and are also found in a variety of other proteins (Corfield et al. 2001; Thornton et al. 2008).”
BackgroundConcepts and Principles of O-Linked Glycosylation
Steen, P. V. D., Rudd, P. M., Dwek, R. A., & Opdenakker, G. (1998) · Critical Reviews in Biochemistry and Molecular Biology · doi:10.1080/10409239891204198 · Cited by 760 · cited 1×
“The surface membranes of mammalian cells are rich in gly-coconjugates which mediate many cellular events and are intimately involved in cell–cell and cell–matrix interactions (Van den Steen et al. 1998).”
BackgroundHague, A., Manning, A. M., Hanlon, K. A., Hart, D., Paraskeva, C., & Huschtscha, L. I. (1993) · International Journal of Cancer · doi:10.1002/ijc.2910550329 · Cited by 530 · cited 9×
“Shed cells were confirmed as apoptotic using a combination of biochemical and morphological assays as described previously by us and others (Hague et al. 1993; Sheng et al. 1998; Diaz et al. 2000).”
BackgroundMethodResultInfluentialSelf-citationBrewer, C. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00364-0 · Cited by 435 · cited 2×
“2004; Dube and Bertozzi 2005) and cell signalling through multivalent protein–glycan networks mediated by galectins (Brewer et al. 2002; Gabius 2006), implicating roles in cell and tissue development and viability.”
BackgroundMucins in the gastrointestinal tract in health and disease
Corfield, A. (2001) · Frontiers in Bioscience · doi:10.2741/corfield · Cited by 344 · cited 2×
“The mucin-type Oglycan chains are linked to serine and threonine through an α-O-glycosyl linkage to N-acetylgalactosamine in well-defined core structures (Corfield et al. 2001; Linden et al. 2008).”
BackgroundHuman MUC1 carcinoma-associated protein confers resistance to genotoxic anticancer agents
Ren, J., Agata, N., Chen, D., Li, Y., Yu, W.-H., Huang, L., Raina, D., Chen, W., Kharbanda, S., & Kufe, D. (2004) · Cancer Cell · doi:10.1016/s1535-6108(04)00020-0 · Cited by 325 · cited 2×
“2003) and the intrinsic pathway (Ren et al. 2004) and is a target for galectin-3 binding through its core 1 glycans (Yu et al.”
BackgroundDíaz, G. D., Paraskeva, C., Thomas, M. G., Binderup, L., & Hague, A. (2000) · PubMed · Cited by 315
Self-citationYu, L.-G., Andrews, N., Zhao, Q., McKean, D., Williams, J. F., Connor, L. J., Gerasimenko, O. V., Hilkens, J., Hirabayashi, J., Kasai, K., et al. (2007) · Journal of Biological Chemistry · doi:10.1074/jbc.m606862200 · Cited by 303 · cited 2×
“2004) and is a target for galectin-3 binding through its core 1 glycans (Yu et al. 2007).”
BackgroundCharacterization of a Mouse Monoclonal Antibody Specific for O-Linked N-Acetylglucosamine
Comer, F. I., Vosseller, K., Wells, L., Accavitti, M. A., & Hart, G. W. (2001) · Analytical Biochemistry · doi:10.1006/abio.2001.5132 · Cited by 295 · cited 1×
“6 (Comer et al. 2001) in PC/AA/C1/SB10C and HCA7/C29 cells.”
Detection of the Ki‐67 antigen in fixed and wax‐embedded sections with the monoclonal antibody MIB1
McCORMICK, D., CHONG, H., HOBBS, C., DATTA, C., & HALL, P. A. (1993) · Histopathology · doi:10.1111/j.1365-2559.1993.tb00135.x · Cited by 294 · cited 1×
“In order to verify the gene array data at the protein level, we chose to investigate the expression of Ki67 a well-known proliferation marker (McCormick et al. 1993).”
BackgroundEvidence of Regio-specific Glycosylation in Human Intestinal Mucins
Robbe, C., Capon, C., Maes, E., Rousset, M., Zweibaum, A., Zanetta, J.-P., & Michalski, J.-C. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m302529200 · Cited by 230 · cited 3×
“External calibration was performed prior to each measure using a 4 pmol/ μ L solution of taurocholic acid in acetonitrile/water (50:50, v/v) containing 2 mM of ammonium acetate (Robbe et al. 2003).”
MethodSelf-citationAmano, M., Galvan, M., He, J., & Baum, L. G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m209595200 · Cited by 212 · cited 2×
“Increased salivation by ST6GAL1 prevents galectin-1 binding and reduces cell death (Amano et al. 2003), while GCNT1 creates viable ligands for galectin-1 and leads to T-cell death (Nguyen et al.”
BackgroundCD45 Modulates Galectin-1-Induced T Cell Death: Regulation by Expression of Core 2 O -Glycans
Nguyen, J. T., Evans, D. P., Galvan, M., Pace, K. E., Leitenberg, D., Bui, T. N., & Baum, L. G. (2001) · The Journal of Immunology · doi:10.4049/jimmunol.167.10.5697 · Cited by 188 · cited 2×
“Increased salivation by ST6GAL1 prevents galectin-1 binding and reduces cell death (Amano et al. 2003), while GCNT1 creates viable ligands for galectin-1 and leads to T-cell death (Nguyen et al. 2001).”
BackgroundApoptosis and colorectal cancer
Watson, A. J. M. (2004) · Gut · doi:10.1136/gut.2004.052704 · Cited by 177 · cited 1×
“Apoptosis is well known as a regulator of cell growth (Watson 2004) and its characteristic patterns are confirmed (Figure 4) through AOEB staining, PARP cleavage, and activation of executioner caspases 3 and 7.”
BackgroundYin, L., Li, Y., Ren, J., Kuwahara, H., & Kufe, D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m301987200 · Cited by 176 · cited 2×
“Further support for a role for O-glycans in apoptosis has come through studies of MUC1 which attenuates oxidative stress-induced apoptosis (Yin et al. 2003) and the intrinsic pathway (Ren et al.”
BackgroundIwai, T., Inaba, N., Naundorf, A., Zhang, Y., Gotoh, M., Iwasaki, H., Kudo, T., Togayachi, A., Ishizuka, Y., Nakanishi, H., et al. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.m112457200 · Cited by 176 · cited 2×
“This corresponds to the B3GALT6 enzyme (Iwai et al. 2002) and may be responsible for the Gal β 1-3Gal β 1–3 structure.”
BackgroundIwai, T., Kudo, T., Kawamoto, R., Kubota, T., Togayachi, A., Hiruma, T., Okada, T., Kawamoto, T., Morozumi, K., & Narimatsu, H. (2005) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0407983102 · Cited by 159 · cited 4×
“The low levels detected correspond to our earlier report of reduced core 3 synthase in a cultured cell model of progression to colorectal cancer (Vavasseur et al. 1994) and in colon carcinoma (Iwai et al. 2005).”
BackgroundMethodInfluentialIsshiki, S., Togayachi, A., Kudo, T., Nishihara, S., Watanabe, M., Kubota, T., Kitajima, M., Shiraishi, N., Sasaki, K., Andoh, T., et al. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.18.12499 · Cited by 146 · cited 2×
“The detection of sialyl-Lewis X (sialyl-Le x ) in aryl-glycans (17 and 25) is consistent with the action of ST3GAL4 (Higai et al. 2006), together with FUT3 and B3GALT5.”
BackgroundMucins in the gastrointestinal tract in health and disease
Corfield, A. P. (2001) · Frontiers in bioscience · doi:10.2741/a684 · Cited by 141
Self-citationGabius, H. (2006) · Critical Reviews in Immunology · doi:10.1615/critrevimmunol.v26.i1.30 · Cited by 139
Paraskeva, C., Buckle, B. G., Sheer, D., & Wigley, C. B. (1984) · International Journal of Cancer · doi:10.1002/ijc.2910340109 · Cited by 138 · cited 2×
“PC/AA/C1 and PC/AA/C1/SB10C cells were cultured in a conditioned medium as previously described (Paraskeva et al. 1984; Williams, Browne, et al. 1993; Williams, Hague, et al. 1993).”
BackgroundMethodSelf-citationO‐glycan biosynthesis in human colorectal adenoma cells during progression to cancer
VAVASSEUR, F., DOLE, K., YANG, J., MATTA, K. L., MYERSCOUGH, N., CORFIELD, A., PARASKEVA, C., & BROCKHAUSEN, I. (1994) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1994.tb18880.x · Cited by 136 · cited 3×
“The low levels detected correspond to our earlier report of reduced core 3 synthase in a cultured cell model of progression to colorectal cancer (Vavasseur et al. 1994) and in colon carcinoma (Iwai et al. 2005).”
BackgroundSelf-citationA disaccharide precursor of sialyl Lewis X inhibits metastatic potential of tumor cells.
Fuster, M. M., Brown, J. R., Wang, L., & Esko, J. D. (2003) · PubMed · Cited by 129
An Inhibitor of the Human UDP-GlcNAc 4-Epimerase Identified from a Uridine-Based Library
Winans, K. A., & Bertozzi, C. R. (2002) · Chemistry & Biology · doi:10.1016/s1074-5521(02)00093-5 · Cited by 77
Huet, G., Gouyer, V., Delacour, D., Richet, C., Zanetta, J., Delannoy, P., & Degand, P. (2003) · Biochimie · doi:10.1016/s0300-9084(03)00056-7 · Cited by 73 · cited 22×
“O Bn GalNAc ( 1 ) inhibition is known to vary (Huet et al. 2003) and is thought to reflect the gly-cosyltransferase complement present (Brown et al. 2003; Huet et al. 2003).”
BackgroundResultInfluentialHennebicq, S., Lesuffleur, T., Capon, C., de Bolós, C., Isabelle, K. I. M., Moreau, O. K., Richet, C., Hémon, B., Krzewinski‐Recchi, M., Maes, E., et al. (1998) · Biochemical Journal · doi:10.1042/bj3340283 · Cited by 70 · cited 6×
“Earlier studies with HT29 MTX cells showed decreased cell numbers after permanent exposure to 1 over 14 days (Hennebicq-Reig et al. 1998; Huet et al. 2003) and evidence of a short-term response after 14 h exposure (Delacour et al.”
BackgroundInfluentialBiosynthesis and expression of the Sda and sialyl Lewis x antigens in normal and cancer colon
Malagolini, N., Santini, D., Chiricolo, M., & Dall'Olio, F. (2007) · Glycobiology · doi:10.1093/glycob/cwm040 · Cited by 59 · cited 2×
“Studies on the molecular biological basis for Sda and sialyl-Lex expression have indicated that a competition between B4GALNT and α1-3/4 fucosyltransferases exists and that this may govern the appearance of ectopic sialyl-Lex on glycoproteins in colon cancer (Malagolini et al. 2007).”
BackgroundRadical-Mediated Synthesis of α-C-Glycosides Based on N-Acyl Galactosamine
SanMartín, R., Tavassoli, B., Walsh, K. E., Walter, D. S., & Gallagher, T. C. (2000) · Organic Letters · doi:10.1021/ol006682c · Cited by 57 · cited 1×
“O Bn GalNAc), shown in Table I, were synthesized (SanMartin et al. 2000; Grant et al. 2002,). α -”
MethodSelf-citationHigai, K., Miyazaki, N., Azuma, Y., & Matsumoto, K. (2006) · FEBS Letters · doi:10.1016/j.febslet.2006.09.073 · Cited by 54 · cited 3×
“The detection of sialyl-Lewis X (sialyl-Le x ) in aryl-glycans (17 and 25) is consistent with the action of ST3GAL4 (Higai et al. 2006), together with FUT3 and B3GALT5.”
Brown, J. R., Fuster, M. M., Whisenant, T. C., & Esko, J. D. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m303093200 · Cited by 52 · cited 8×
“O Bn GalNAc ( 1 ) inhibition is known to vary (Huet et al. 2003) and is thought to reflect the gly-cosyltransferase complement present (Brown et al. 2003; Huet et al. 2003).”
BackgroundMethodInfluentialSynthesis and glycan priming activity of acetylated disaccharides
Sarkar, A. K., Brown, J. R., & Esko, J. D. (2000) · Carbohydrate Research · doi:10.1016/s0008-6215(00)00200-7 · Cited by 45 · cited 11×
“The effective use of such structures as inhibitors requires their transport into the cells, and this has been identified as a limitation (Sarkar et al. 2000).”
BackgroundInfluentialGalacto, Gluco, Manno, and Disaccharide-Based C-Glycosides of 2-Amino-2-deoxy Sugars
Grant, L., Liu, Y., Walsh, K. E., Walter, D. S., & Gallagher, T. C. (2002) · Organic Letters · doi:10.1021/ol0269695 · Cited by 40 · cited 1×
“O Bn GalNAc), shown in Table I, were synthesized (SanMartin et al. 2000; Grant et al. 2002,). α -”
MethodSelf-citationGouyer, V., Leteurtre, E., Zanetta, J. P., Lesuffleur, T., Delannoy, P., & Huet, G. (2001) · Frontiers in bioscience · doi:10.2741/gouyer · Cited by 39 · cited 8×
“Peanut lectin (PNA) recognizes the disaccharide Gal β 1-3GalNAc-R (core 1 or Thomsen–Friedenreich (TF) antigen) and has a general affinity for glycans with terminal β Gal residues (Gouyer et al. 2001).”
BackgroundResultInfluentialWilliams, A. C., Browne, S. J., Yeudal, W. A., Paterson, I. C., Marshall, C. J., Lane, D. P., & Paraskeva, C. (1993) · PubMed · Cited by 36
Self-citationZanetta, J., Gouyer, V., Maes, E., Pons, A., Hémon, B., Zweibaum, A., Delannoy, P., & Huet, G. (2000) · Glycobiology · doi:10.1093/glycob/10.6.565 · Cited by 35 · cited 20×
“Thus, chemical manipulation of the α-OBn GalNAc structure yields new information on the sites of inhibition throughout the O-glycosylation pathways and expands previous data with HT29 cell lines for α-OBn GalNAc (1) alone (Zanetta et al. 2000).”
BackgroundMethodResultInfluentialDelacour, D., Gouyer, V., Leteurtre, E., Aït‐Slimane, T., Drobecq, H., Lenoir, C., Moreau-Hannedouche, O., Trugnan, G., & Huet, G. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m305755200 · Cited by 34 · cited 4×
“2003) in addition to a specific decrease in apical cell membrane glycoproteins (Ulloa et al. 2000; Delacour et al. 2003; Huet et al. 2003).”
BackgroundInfluentialTwo different glycosyltransferase defects that result in GalNAcα-O-peptide (Tn) expression
King, M., Chan, A., Roe, R., Warren, B. F., Dell, A., Morris, H. R., Bartolo, D. C. C., Durdey, P., & Corfield, A. P. (1994) · Glycobiology · doi:10.1093/glycob/4.3.267 · Cited by 32 · cited 4×
“Human colorectal mucosal cells were prepared from resection margin tissue obtained at surgery as described before (King et al. 1994).”
MethodInfluentialSelf-citationKlein, A., Guhl, E., Zollinger, R., Tzeng, Y., Wessel, R., Hummel, M., Graessmann, M., & Graessmann, A. (2005) · Journal of Molecular Medicine · doi:10.1007/s00109-004-0625-1 · Cited by 28 · cited 2×
“Further analyses were performed with the software “CorrX-pression,” which is described in detail elsewhere (Klein et al. 2005; Wessel et al. 2006).”
MethodSelf-citationStructural Determination of O-Glycans by Tandem Mass Spectrometry
Masselot, C. R., Michalski, J., & Capon, C. (2006) · Humana Press eBooks · doi:10.1385/1-59745-167-3:109 · Cited by 28 · cited 1×
“A series of diagnostic ions were used to determine the linkages between monosaccharides (Robbe et al. 2006).”
MethodSelf-citationLi, Y., Yang, X., Nguyen, A. H. T., & Brockhausen, I. (2007) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2007.04.002 · Cited by 27 · cited 3×
“O Bn GalNAc has been shown to induce an increase in apoptosis (Li et al. 2007).”
BackgroundResultInfluentialUlloa, F., Francí, C., & Real, F. X. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.m000510200 · Cited by 24 · cited 1×
“O Bn GalNAc (Hennebicq-Reig et al. 1998; Huet et al. 2003) in addition to a specific decrease in apical cell membrane glycoproteins (Ulloa et al. 2000; Delacour et al. 2003; Huet et al. 2003).”
BackgroundUlloa, F., & Real, F. X. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m211909200 · Cited by 19 · cited 2×
“…culture studies; as O -glycosylation is implicated in galectin-based membrane trafficking, cell signalling (Fuster et al. 2003; Huet et al. 2003; Ulloa and Real 2003; Gabius 2006), and apoptosis (Gabius 2006), it was attractive to focus attention on a potential role in the regulation of cell…”
BackgroundLeteurtre, E., Gouyer, V., Delacour, D., Hémon, B., Pons, A., Richet, C., Zanetta, J., & Huet, G. (2003) · Journal of Histochemistry & Cytochemistry · doi:10.1177/002215540305100310 · Cited by 14 · cited 2×
“The inhibition of apical targeting and cellular events linked with the storage of the α-OBn GalNAc metabolites occur as independent events (Leteurtre et al. 2003).”
BackgroundIn vitro models of human colorectal cancer.
Williams, A. C., Hague, A., Manning, A., van der Stappen, J. W. J., & Paraskeva, C. (1993) · PubMed · Cited by 12
Self-citationChemo-enzymatic synthesis of conformationally constrained oligosaccharides
Galán, M. C., Venot, A. P., Glushka, J., Imberty, A., & Boons, G. (2003) · Organic & Biomolecular Chemistry · doi:10.1039/b308559g · Cited by 11 · cited 1×
“The synthesis of benzyl–phenyl–ethyl and cyclo-hexyl glycosides yielded aglycones with varying hydrophobic character and distance between the sugar ring and the aglycone and is designed to probe the importance of the protein–sugar glycosidic conformation (Galan et al. 2003).”
BackgroundWessel, R., FOOS, V., Aspelmeier, A., Jürgens, M., Graessmann, A., & Klein, A. (2006) · In Silico Biology · doi:10.3233/isb-00222 · Cited by 10 · cited 2×
“Further analyses were performed with the software “CorrX-pression,” which is described in detail elsewhere (Klein et al. 2005; Wessel et al. 2006).”
MethodSelf-citation
Research works printed but not linked: 1
- Schachter, 1992, The biosynthesis of serine (threonine)-N-acetylgalactosamine-linked carbohydrate moieties, 263
Cited by
A glycobiology review: Carbohydrates, lectins and implications in cancer therapeutics
Ghazarian, H., Idoni, B., & Oppenheimer, S. B. (2011) · Acta Histochemica · doi:10.1016/j.acthis.2010.02.004 · Cited by 433
“Here, the C-1 of N-acetylgalactosamine is covalently bonded to the hydroxyl of serine or threonine of the target polypeptide chain (core protein) (Rottger et al., 1998; Patsos et al., 2009).”
BackgroundInfluentialGlycosylation Characteristics of Colorectal Cancer
Holst, S., Wuhrer, M., & Rombouts, Y. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.11.004 · Cited by 173
Drug resistance related to aberrant glycosylation in colorectal cancer
Very, N., Lefebvre, T., & Yazidi‐Belkoura, I. E. (2017) · Oncotarget · doi:10.18632/oncotarget.22377 · Cited by 122
“Treatment of CRC cells with benzyl-2-acetamido2-deoxy-α-D-galactopyranoside (benzyl-α-GalNAc), a structural analog of α-GalNAc linked to serine or threonine residue which competitively inhibits core 1 O-glycans extension, or benzyl-α-GalNAc-derived oligosaccharides has been shown to induce apoptosis [112] and reduce s…”
BackgroundHarvey, D. J. (2010) · Mass Spectrometry Reviews · doi:10.1002/mas.20265 · Cited by 105
Ferreira, J. A., Magalhães, A., Gomes, J., Peixoto, A., Gaiteiro, C., Fernandes, E., Santos, L. L., & Reis, C. A. (2016) · Cancer Letters · doi:10.1016/j.canlet.2016.01.044 · Cited by 107
Metadata
- Authors
- Patsos, G., Hebbe-Viton, V., Robbe-Masselot, C., Masselot, D., Martin, R. S., Greenwood, R., Paraskeva, C., Klein, A., Graessmann, M., Michalski, J. C., Gallagher, T., & Corfield, A.
- Affiliations
- University of Bristol (GB)
- Charité – Universitätsmedizin Berlin (DE)
- Centre National de la Recherche Scientifique (FR)
- Venue
- Glycobiology
- Publisher
- Oxford University Press (OUP)
- Published
- 2009-01-03
- Volume
- 19
- Issue
- 4
- Pages
- 382-398
- ISSN
- 0959-6658 (ISSN-L)
- 1460-2423
- OpenAlex
- W2106498299
- Cited by
- 68
- References
- 54
- Citations by year
- 2026: 3 · 2025: 1 · 2024: 29 · 2023: 1 · 2022: 3 · 2020: 1 · 2019: 1 · 2018: 1 · 2017: 5 · 2016: 4 · 2015: 7 · 2014: 1 · 2013: 2 · 2012: 2
- FWCI
- 1.21
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- Glycobiology (publishedVersion)
- PubMed (publishedVersion)
- Explore Bristol Research (publishedVersion)
- Explore Bristol Research (submittedVersion)
- Bristol Research (University of Bristol) (submittedVersion)
- Funders
- Biotechnology and Biological Sciences Research Council (B19303)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Glycosylation and Glycoproteins Research
- Physical Sciences › Chemistry › Organic Chemistry › Carbohydrate Chemistry and Synthesis
- Physical Sciences › Chemistry › Organic Chemistry › Natural product bioactivities and synthesis
- Keywords
- glycosyltransferase inhibition, apoptosis, colorectal cancer cell lines, cell growth inhibition, protein glycosylation, C-glycosides, growth arrest
- MeSH terms
- Drug Screening Assays, Antitumor, Enzyme Inhibitors, Galactose, Glycoproteins, Glycosylation, Humans, Neoplasm Proteins, Colorectal Neoplasms, Glycosyltransferases, Apoptosis, Caco-2 Cells, Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization, Cell Proliferation
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.